Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 5'-AMP-activated protein kinase catalytic subunit alpha-1-Sirtuin 1 axis (AMPKα1-SIRT1 axis) is a fundamental energy-sensing signaling pathway that regulates cellular metabolism and homeostasis [Cantó et al., 2009, Nature]. AMPK acts as a metabolic master switch that, upon activation by low energy status, increases the intracellular concentration of NAD+, which in turn activates the NAD+-dependent deacetylase SIRT1 [Ruderman et al., 2010, AJP-Endo]. SIRT1 further reinforces this pathway by deacetylating and activating LKB1, the upstream kinase required for AMPK phosphorylation, creating a reciprocal activation loop [Price et al., 2012, Cell Metabolism]. This axis is a major regulator of mitochondrial biogenesis, fatty acid oxidation, and glucose uptake, making it a primary therapeutic interest for metabolic disorders such as type 2 diabetes, obesity, and non-alcoholic fatty liver disease [Hardie, 2014, J Intern Med]. Pharmacological agents like metformin and resveratrol are known to modulate this axis, although their effects are often indirect. While activation of the AMPKα1-SIRT1 axis generally promotes metabolic health and longevity, its role in oncology is complex, as it can act as a tumor suppressor in early stages but may support the survival of established cancer cells under nutrient-deprived conditions.
Activation of the AMPK-SIRT1 pathway involves a reciprocal regulatory loop where AMPK increases NAD+ levels to activate SIRT1, and SIRT1 deacetylates LKB1 to activate AMPK, leading to the downstream activation of PGC-1alpha and FOXO1 to enhance metabolic efficiency.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5'-AMP-activated protein kinase catalytic subunit alpha-1-Sirtuin 1 axis (AMPKα1-SIRT1 axis).